Neutrophil gelatinase-associated apolipoprotein detection kit and fluorescent quantitative detection method

Through the competitive fluorescence quantitative detection method of NGAL fluorescence sensor combining with reporter molecules, the complex operation, time-consuming and cost of NGAL quantitative detection is solved, and the rapid, sensitive and low-cost gelatinase-related loading of neutrophils is achieved. Lipoprotein detection, with high stability and specificity.

CN118914576APending Publication Date: 2024-11-08JILIN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411000981.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing quantitative detection methods for gelatinase-related apolipoprotein (NGAL) in neutrophils are complex in operation, have a long detection time, have a narrow linear range, high equipment requirements, and are costly, making it difficult to meet the fast, sensitive and low-cost detection needs. .

Method used

Using a competitive fluorescence quantitative detection method that combines NGAL fluorescence sensor with reporter molecules, NGAL is recognized by G-quadruple structure and NGAL nucleic acid aptamer to achieve rapid and sensitive fluorescence quantitative detection, including dilution gradient dilution, activation treatment and Fluorescence signal detection, establish standard working curves to achieve quantitative analysis.

Benefits of technology

The rapid quantitative detection of NGAL is realized, with a detection time of less than 10 minutes, high sensitivity, wide linear range (1~1000μg/L), and biosensors can be produced on a large scale, with low cost, simple operation, and high stability and specificity. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914576A_ABST
    Figure CN118914576A_ABST
Patent Text Reader

Abstract

The invention discloses a neutrophil gelatinase-associated apolipoprotein detection kit and a fluorescent quantitative detection method. The kit comprises an NGAL fluorescence sensor, a reporter molecule and an NGAL standard substance, the NGAL molecule can compete with the reporter molecule to be combined with the NGAL fluorescence sensor; the NGAL fluorescence sensor comprises a nucleotide chain with a G-quadruplex structure and an NGAL nucleic acid aptamer structure; the reporter molecule is a fluorescent dye molecule or a substance marked by the fluorescent dye molecule which can be specifically combined with the G-quadruplex structure and can generate a fluorescence signal. According to the detection method, NGAL molecules and reporter molecules are competitively combined with an NGAL fluorescence sensor, so that NGAL quantification is realized according to the change of the fluorescence intensity of the reporter molecules. When the kit and the fluorescent quantitative detection method provided by the invention are used for NGAL quantification, the kit and the fluorescent quantitative detection method have the advantages of less detection time consumption, low preparation cost, wide detection linear range, simplicity in operation and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of protein quantitative detection, and specifically relates to a neutrophil gelatinase-associated apolipoprotein detection kit and a fluorescence quantitative detection method. Background Art

[0002] Neutrophil gelatinase-associated lipocalin (NGAL), also known as human neutrophil 1ipocalin (HNL), is a glycoprotein involved in physiological and pathological processes such as cell proliferation, tumors, kidney damage, and acute infection. Accurate quantification of NGAL is helpful for laboratory research and clinical application of NGAL. Western blotting (Mishra J, et al. 2004, Am J Nephrol, 24 (3): 307-315), radioimmunoassay (Xu SY, et al. 1994. J Immunol Methods, 171 (2): 245-252), enzyme-linked immunosorbent assay (Krzeminska E, et al. 2016, J Clin Lab Ana1, 30 (6): 956-960, Cai, L, 2009. Clinica Chimica Acta, 403 (1-2): 121-125), chemiluminescent immunoassay (Hawksworth D, et al. 2012. Hybridoma (Larchmt), 31 (6): 436-442), particle-enhanced turbidimetric immunoassay (Hansen YB, et al. 2014. Scand J Clin Lab Invest, 74(1): 20-26) and other NGAL quantitative methods have the disadvantages of complex operation, long detection time, narrow linear range, high equipment requirements, etc. Therefore, a NGAL quantitative detection product and method with simple detection steps, short detection time, wide linear range and low preparation cost is needed to achieve rapid NGAL quantification. Summary of the invention

[0003] The main purpose of the present invention is to provide a neutrophil gelatinase-associated apolipoprotein detection kit and a fluorescence quantitative detection method for non-clinical diagnosis, so as to overcome the shortcomings of the prior art.

[0004] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention includes:

[0005] The present invention provides a neutrophil gelatinase-associated lipocalin detection kit, which comprises an NGAL fluorescent sensor, a reporter molecule, and an NGAL standard; wherein the NGAL molecule can compete with the reporter molecule for binding to the NGAL fluorescent sensor; the NGAL fluorescent sensor comprises a nucleotide chain having a G-quadruplex structure and an NGAL nucleic acid aptamer structure; and the reporter molecule is a fluorescent dye molecule or a substance labeled with a fluorescent dye molecule that can specifically bind to the G-quadruplex structure and generate a fluorescent signal.

[0006] The present invention also provides the use of the aforementioned neutrophil gelatinase-associated lipocalin detection kit in preparing a product for fluorescent detection of neutrophil gelatinase-associated lipocalin.

[0007] The present invention also provides a method for fluorescence quantitative detection of neutrophil gelatinase-associated apolipoprotein, which comprises:

[0008] Using the diluent to perform gradient dilution on the NGAL standard to obtain a gradient working solution of the NGAL standard;

[0009] Diluting the sample to be tested with a diluent to obtain a sample test solution;

[0010] The NGAL fluorescent sensor is activated, and then mixed with the reporter molecule, the sample test solution, and the NGAL standard gradient working solution for incubation, and then fluorescence detection is performed to obtain the fluorescence signal intensity of the sample test solution and the NGAL standard gradient working solution;

[0011] According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution, a standard working curve of NGAL concentration and fluorescence signal intensity was established;

[0012] According to the fluorescence intensity of the sample test solution and the aforementioned standard working curve, the fluorescence quantitative detection of neutrophil gelatinase-associated lipocalin can be achieved.

[0013] Compared with the prior art, the present invention has the following beneficial effects:

[0014] (1) When the neutrophil gelatinase-associated lipocalin detection kit of the present invention is used for fluorescent quantitative detection of NGAL, the detection takes less time and NGAL quantification can be achieved within 10 minutes;

[0015] (2) The neutrophil gelatinase-associated lipocalin detection kit of the present invention has high sensitivity and a wide detection linear range for fluorescent quantitative detection of NGAL, and its linear range is 1 to 1000 μg / L;

[0016] (3) The NGAL biosensor in the neutrophil gelatinase-associated lipocalin detection kit of the present invention is artificially synthesized in vitro, can be produced on a large scale, and does not require modification of molecules such as biotin and fluorescein. It is simple to prepare, has low production cost, small batch-to-batch differences, has uniform and stable properties, and can be stored at room temperature;

[0017] (4) The nucleic acid aptamer sequence in the NGAL biosensor in the neutrophil gelatinase-associated lipocalin detection kit of the present invention has the characteristic of specifically recognizing NGAL, which can ensure the specificity of the detection;

[0018] (5) The detection kit and fluorescence quantitative detection method of neutrophil gelatinase-associated lipocalin of the present invention have a simple reaction system, few steps and are easy to operate, and have low technical requirements for test personnel. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0020] Figure 1 Schematic diagram of the composition of a kit in a typical embodiment of the present invention, wherein 1 is an NGAL standard, 2 is an NGAL fluorescent sensor, 3 is a reporter molecule, 4 is a diluent, and 5 is a microplate for fluorescence detection;

[0021] Figure 2 : is a standard curve diagram of the NGAL fluorescence quantitative detection method (method A) in a typical embodiment of the present invention, the standard curve is drawn according to the data in Table 2, wherein the abscissa is the NGAL concentration and the ordinate is the fluorescence signal intensity;

[0022] Figure 3 The standard curve of the NGAL fluorescence quantitative detection method (method B) in a typical embodiment of the present invention is drawn according to the data in Table 2, wherein the abscissa is the NGAL concentration and the ordinate is the fluorescence signal intensity;

[0023] Figure 4 The standard curve of the ELISA quantitative method of NGAL in a typical embodiment of the present invention is drawn according to the data in Table 3, wherein the abscissa is the NGAL concentration and the ordinate is the absorbance;

[0024] Figure 5The figure is a graph showing the detection results of the same sample by the fluorescence quantitative detection method (method A) and the ELISA detection method of NGAL in a typical embodiment of the present invention, and the figure is drawn according to the data in Table 4, wherein the abscissa is the NGAL concentration in the sample measured by the fluorescence quantitative detection method (method A), and the ordinate is the NGAL concentration in the sample measured by the ELISA method;

[0025] Figure 6 The figure is a graph showing the detection results of the same sample by the fluorescence quantitative detection method (method B) of NGAL and the ELISA detection method of NGAL in a typical embodiment of the present invention. The figure is drawn according to the data in Table 4, wherein the abscissa is the NGAL concentration in the sample measured by the fluorescence quantitative detection method B, and the ordinate is the NGAL concentration in the sample measured by the ELISA method;

[0026] Figure 7 This is a graph showing the detection results of the same sample by two fluorescent quantitative detection methods of NGAL in a typical embodiment of the present invention. The graph is drawn based on the data in Table 4, wherein the horizontal axis is the NGAL concentration in the sample measured by the fluorescent quantitative detection method of NGAL (method A), and the vertical axis is the NGAL concentration in the sample measured by the fluorescent quantitative detection method of NGAL (method B). DETAILED DESCRIPTION

[0027] In view of the defects of the prior art, the inventors of this case have proposed the technical solution of the present invention after long-term research and extensive practice. The present invention realizes the specific and rapid quantification of NGAL by competitive binding of NGAL and reporter molecules to NGAL fluorescent sensor and then changes in the fluorescence intensity of the reporter molecules. It has significant advantages such as high detection sensitivity, wide linear detection range, high stability, low preparation cost, simple operation and less detection time.

[0028] The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0029] Specifically, as one aspect of the technical solution of the present invention, a neutrophil gelatinase-associated lipocalin detection kit involves an NGAL fluorescent sensor, a reporter molecule, and an NGAL standard; wherein the NGAL molecule can compete with the reporter molecule for binding to the NGAL fluorescent sensor; the NGAL fluorescent sensor includes a nucleotide chain having a G-quadruplex structure and an NGAL nucleic acid aptamer structure; the reporter molecule is a fluorescent dye molecule or a substance labeled with a fluorescent dye molecule that can specifically bind to the G-quadruplex structure and generate a fluorescent signal.

[0030] Specifically, the composition diagram of the detection kit for neutrophil gelatinase-associated apolipoprotein in the present application is as follows: Figure 1 As shown, it includes: NGAL standard 1, NGAL fluorescent sensor 2, reporter molecule 3, diluent 4, and microplate 5 for fluorescence detection.

[0031] In some preferred embodiments, the NGAL fluorescent sensor and the reporter molecule exist independently in the kit; or, the NGAL fluorescent sensor and the reporter molecule are pre-mixed and exist in the kit as a mixture.

[0032] In some preferred embodiments, the G-quartet is composed of 2 or more G-quartet structural units.

[0033] In some preferred embodiments, the NGAL fluorescent sensor, reporter molecule and NGAL standard are stored in the form of lyophilized powder or solution.

[0034] Furthermore, the NGAL fluorescent sensor is stored in the form of freeze-dried powder.

[0035] The nucleotide chain sequence of the NGAL fluorescent sensor in the present invention includes but is not limited to the nucleotide sequence shown in any one of SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6, SEQ ID No.7, SEQ ID No.8, SEQ ID No.9 and SEQ ID No.10, preferably SEQ ID No.1. Specifically shown in Table 1 below:

[0036] Table 1

[0037]

[0038] In some preferred embodiments, the reporter molecule is a fluorescent dye molecule that can specifically bind to the G-quadruplex structure and generate fluorescence, or a substance labeled with a fluorescent dye molecule, wherein the fluorescent dye molecule includes but is not limited to Thioflavin T (ThT), N-methylmorpholine (N-MethylMesoporphyrinIX, NMM), 4-(2-aminoethoxy)-N2,N6-di[4-(2-aminoethoxy)-2-quinolyl]-2,6-pyridinedicarboxamide (Pyridostatin, PDS), Triphenylmethanol-4,4′,4″-tricarboxylic acid (Triarylmethane Dye, TOTA), BMVC (3,6-Bis(1-methyl-4-vinylpyridinium)carbazole diiodide), Cy5 or Cy7; the substance labeled with the fluorescent dye molecule includes but is not limited to Berberine, Chelerythrine, G-quadruplex recognition peptide, G-quadruplex binding protein or G-quadruplex nucleic acid aptamer modified with the fluorescent dye molecule.

[0039] Furthermore, the fluorescent dye molecule is Thioflavin T (ThT).

[0040] In some preferred embodiments, the NGAL standard is NGAL solution or NGAL lyophilized powder.

[0041] Furthermore, the NGAL standard product is NGAL freeze-dried powder.

[0042] Furthermore, the NGAL concentration in the NGAL solution is above 1 mg / mL.

[0043] Furthermore, the buffer in the NGAL solution is Hepes buffer or phosphate buffer or Tris buffer, and a protein protective agent is preferably added to the buffer, and the protein protective agent is preferably sodium azide.

[0044] In some preferred embodiments, the kit further comprises a diluent for diluting the NGAL standard and the sample to be tested.

[0045] Furthermore, the diluent includes but is not limited to Hepes buffer, phosphate buffer or Tris buffer.

[0046] In some preferred embodiments, the sample to be detected includes any biological sample of serum, plasma, urine, tears, saliva, cerebrospinal fluid, lung washing fluid, and tissue homogenate.

[0047] In some more specific embodiments, the neutrophil gelatinase-associated lipocalin detection kit comprises: NGAL standard, NGAL fluorescent sensor, reporter molecule, diluent and microplate for fluorescence detection.

[0048] Preferably, the NGAL standard is an NGAL solution of known concentration or its lyophilized powder, preferably an NGAL solution (concentration ≥ 1 mg / mL) dissolved in 50 mM Tris buffer (pH = 7.2-7.5) or 10 mM phosphate buffer (pH = 7.2-7.5), more preferably an NGAL solution containing a protein protective agent, the protein protective agent is preferably 0.02-0.05% (w / v) NaN3, and further preferably the NGAL solution is made into a lyophilized powder.

[0049] Preferably, the NGAL fluorescent sensor is a nucleotide chain having a G-quadruplex structure and a NGAL nucleic acid aptamer structure, wherein the G-quadruplex structure is composed of two or more G-tetrad structures, and the sequence of the nucleotide chain is preferably but not limited to 5'-AGGGACGGGAATGGCGGAGCTGGATAGTATAGTCGGAGGGACGGGA-3', and the NGAL fluorescent sensor is stored in the form of a lyophilized powder or a solution, and the NGAL fluorescent sensor is preferably stored in the form of a lyophilized powder. Preferably, the reporter molecule is a fluorescent dye molecule, and the fluorescent dye includes Thioflavin T (ThT), N-MethylMesoporphyrin IX (NMM), Pyridostatin (PDS), Triarylmethane Dye (TOTA), 3,6-Bis (1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC), Cy5, Cy7 and the like, which can bind to the G-quadruplex structure in the aforementioned NGAL fluorescent sensor to generate a fluorescent signal, and the reporter molecule is preferably Thioflavin T (ThT).

[0050] Preferably, the diluent is used for diluting the standard and the sample to be detected, preferably Hepes buffer (10mM, pH=7.0-7.4), Tris buffer (50mM, pH=7.2-7.5) or phosphate buffer (10mM, pH=7.2-7.5), and the sample to be detected includes but is not limited to biological samples such as serum, plasma, urine, tears, saliva, cerebrospinal fluid, lung washing fluid, tissue homogenate, etc.

[0051] Another aspect of the embodiments of the present invention further provides the use of the aforementioned neutrophil gelatinase-associated lipocalin detection kit in the preparation of a product for fluorescent detection of neutrophil gelatinase-associated lipocalin.

[0052] Another aspect of the embodiments of the present invention further provides a method for fluorescence quantitative detection of neutrophil gelatinase-associated apolipoprotein, comprising:

[0053] Using the diluent to perform gradient dilution on the NGAL standard to obtain a gradient working solution of the NGAL standard;

[0054] Diluting the sample to be tested with a diluent to obtain a sample test solution;

[0055] The NGAL fluorescent sensor is activated, and then mixed with the reporter molecule, the sample test solution, and the NGAL standard gradient working solution and incubated, and then fluorescence detection is performed to obtain the fluorescence signal intensity of the sample test solution and the NGAL standard gradient working solution;

[0056] According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution, a standard working curve of NGAL concentration and fluorescence signal intensity was established;

[0057] According to the fluorescence signal intensity of the sample test solution and the standard working curve, the fluorescence quantitative detection of neutrophil gelatinase-associated lipocalin is achieved.

[0058] In some preferred embodiments, the concentration of the gradient working solution of the NGAL standard is 1-1000 μg / L.

[0059] In some preferred embodiments, the activation treatment includes but is not limited to activation by heat treatment method, activation by cationic treatment method, and activation by ultrasonic treatment method, preferably activation by heat treatment method, wherein the conditions for activation by heat treatment method include: mixing Tris hydrochloric acid buffer with NGAL fluorescent sensor and heating at 95°C for 5 to 10 minutes.

[0060] In some preferred embodiments, the fluorescence quantitative detection method specifically includes: mixing the activated NGAL fluorescent sensor with the reporter molecule and incubating for not less than 5 minutes, and then mixing with the gradient working solution of the NGAL standard and the sample test solution and incubating for 5 to 20 minutes before detecting the fluorescence signal; or, mixing the NGAL fluorescent sensor with the gradient working solution of the NGAL standard and the sample test solution and incubating for not less than 5 minutes, and then mixing with the reporter molecule and incubating for 1 to 20 minutes before detecting the fluorescence signal.

[0061] In some more specific embodiments, the method for fluorescent quantitative detection of neutrophil gelatinase-associated lipocalin comprises:

[0062] (1) using a diluent to perform a gradient dilution of the NGAL standard (preferably a two-fold gradient dilution, at least four gradients) to obtain a NGAL standard working solution;

[0063] (2) diluting the biological sample to be tested with a diluent (preferably, the dilution factor for urine, cerebrospinal fluid and tears is ≥2 times, and the dilution factor for other biological samples is ≥5 times) to obtain a sample test solution;

[0064] (3) Activation of NGAL fluorescent sensor: Dissolve NGAL fluorescent sensor freeze-dried powder in 10 mM Tris buffer (pH 7.2-7.5, containing 25-150 mM NaCl or KCl, preferably containing 100 mM NaCl or KCl) to obtain 0.2-10 μM NGAL fluorescent sensor; heat at 95° C. for 5-10 min, and cool naturally to room temperature to obtain NGAL fluorescent sensor working solution;

[0065] (4) Preparation of reporter molecule working solution: Dissolve the reporter molecule in 10 mM Tris buffer (pH = 7.2-7.5) to obtain 1-20 μM reporter molecule working solution;

[0066] (5) mixing the reporter molecule working solution and the NGAL fluorescent sensor working solution to obtain solution A;

[0067] (6) incubating the NGAL standard working solution prepared in step (1) and the sample test solution prepared in step (2) with solution A for 5 to 20 minutes, preferably 10 minutes;

[0068] (7) Detecting fluorescence signals using a fluorescence detector;

[0069] (8) establishing a standard working curve of NGAL concentration and fluorescence signal intensity according to the NGAL concentration in the NGAL standard gradient working solution obtained in step (7) and the corresponding fluorescence signal intensity;

[0070] (9) Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in step (7) and the standard working curve established in step (8).

[0071] Preferably, the concentration range of the NGAL standard working solution is 1 to 1000 μg / L.

[0072] Preferably, the aforementioned fluorescence quantitative detection method can take as little as 5 minutes.

[0073] Preferably, the order of steps (5) and (6) can be changed, that is, the NGAL fluorescent sensor working solution can be first incubated with the reporter molecule working solution and then incubated with the NGAL standard working solution or sample solution, or the NGAL fluorescent sensor working solution can be first incubated with the NGAL standard working solution or sample solution and then incubated with the reporter molecule for a certain time (preferably ≥5 min). Preferably, the NGAL fluorescent sensor working solution is first incubated with the reporter molecule and then incubated with the NGAL standard working solution or sample solution.

[0074] In some preferred embodiments, the method for fluorescence quantitative detection of neutrophil gelatinase-associated apolipoprotein comprises:

[0075] (1) Using a diluent, the NGAL standard is diluted in a gradient manner, and the 1000 μg / L NGAL standard solution is diluted two-fold in 10 gradients to 0.98 μg / L to obtain an NGAL standard working solution;

[0076] (2) diluting the biological sample to be tested with a diluent (preferably, the dilution factor for urine, cerebrospinal fluid and tears is ≥2 times, and the dilution factor for other biological samples is ≥5 times) to obtain a sample test solution;

[0077] (3) Activation of NGAL fluorescent sensor: NGAL fluorescent sensor freeze-dried powder was dissolved in 10 mM Tris buffer (pH = 7.2-7.5, containing 25-150 mM NaCl or KCl, preferably containing 100 mM NaCl or KCl) to obtain 1 μM NGAL fluorescent sensor; after heating at 95° C. for 5-10 min, it was naturally cooled to room temperature to obtain NGAL fluorescent sensor working solution;

[0078] (4) Preparation of reporter molecule working solution: Dissolve Thioflavin T (ThT) molecules in 10 mM Tris buffer (pH = 7.2-7.5) to obtain a 10 μM Thioflavin T (ThT) solution.

[0079] (5) mixing equal volumes of the Thioflavin T (ThT) solution prepared in step (4) and the NGAL fluorescent sensor working solution having a sequence of SEQ ID No. 1 prepared in step (3) to obtain solution A;

[0080] (6) mixing the NGAL standard working solution prepared in step (1) and the sample test solution prepared in step (2) with equal volumes of solution A prepared in step (5) (preferably 50 μL each) and incubating for 5 to 20 minutes, preferably 10 minutes;

[0081] (7) using a fluorescence detector to detect the fluorescence signal of Thioflavin T (ThT), wherein the excitation wavelength is 440 nm to 450 nm and the detection emission wavelength range is 480 nm to 490 nm;

[0082] (8) establishing a standard working curve of NGAL concentration and fluorescence signal intensity according to the NGAL concentration in the NGAL standard gradient working solution obtained in step (7) and the corresponding fluorescence signal intensity;

[0083] (9) Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in step (7) and the standard working curve established in step (8).

[0084] The technical solution of the present invention is further described in detail below in conjunction with several preferred embodiments and drawings. This embodiment is implemented on the premise of the technical solution of the invention, and a detailed implementation method and specific operation process are given, but the protection scope of the present invention is not limited to the following embodiments.

[0085] Unless otherwise specified, the experimental materials used in the following examples can be purchased from conventional biochemical reagent companies.

[0086] Example 1 Composition of a Neutrophil Gelatinase-Associated Apolipoprotein Detection Kit

[0087] The kit consists of: 1 bottle of NGAL standard, 1 bottle of NGAL fluorescent sensor, 1 bottle of reporter molecule solution, 1 bottle of diluent and 1 fluorescence detection microplate.

[0088] The NGAL standard product is 2 μg of NGAL freeze-dried powder, which is obtained by expression, purification, mass spectrometry quantification and freeze-drying by a baculovirus-insect cell expression system.

[0089] The sequence number of the NGAL fluorescent sensor is SEQ ID No. 1, and the amount is 20 nmol (synthesized by Sangon Biotechnology (Shanghai) Co., Ltd.);

[0090] The reporter molecule solution was a 10 μM Thioflavin T (ThT) solution (Aladdin, T168914) with a volume of 3 mL;

[0091] The diluent is used for diluting NGAL standard and samples to be tested, and is 50 mM Tris buffer (pH = 7.2-7.5) with a volume of 20 mL;

[0092] The fluorescence detection microplate is a black 96-well plate (Unionwell, 6005270).

[0093] Example 2 A method for quantitative fluorescence detection of neutrophil gelatinase-associated apolipoprotein - method A

[0094] This example illustrates the method for fluorescent quantitative detection of neutrophil gelatinase-associated apolipoprotein (referred to as method A) of the present invention by describing a specific use step of the kit described in Example 1. The specific use steps are as follows:

[0095] Step 1: Dissolve the NGAL standard lyophilized powder with diluent to obtain a 1000 μg / L NGAL standard stock solution, and then perform gradient dilution on the NGAL standard stock solution to obtain at least 4 concentration gradients of NGAL standard working solutions;

[0096] Step 2: Dilute the biological sample to be tested with diluent (preferably urine, cerebrospinal fluid and tears dilution multiples ≥ 2 times, other biological samples were diluted ≥5 times) to obtain the sample test solution;

[0097] Step 3: Dissolve the NGAL fluorescent sensor freeze-dried powder in 10 mM Tris buffer (pH = 7.2-7.5, containing 100 mM NaCl) to prepare a 1 μM NGAL fluorescent sensor solution; heat at 95°C for 5-10 min, and then cool naturally to room temperature to obtain the NGAL fluorescent sensor working solution;

[0098] Step 4: Mix equal volumes of the reporter molecule solution and the NGAL fluorescent sensor working solution prepared in Step 3, and incubate at room temperature for ≥5 min to obtain solution A;

[0099] Step 5: Incubate 50 μL of NGAL standard working solution prepared in Step 1 and 50 μL of sample test solution prepared in Step 2 with 50 μL of solution A prepared in Step 4 for 5 to 20 min respectively;

[0100] Step 6: Use a fluorescence detector to detect the fluorescence signal of the reporter molecule, where the excitation wavelength is 440nm~450nm and the detection emission wavelength range is 480nm~490nm;

[0101] Step 7: According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution obtained in Step 6, a standard working curve of NGAL concentration and fluorescence signal intensity is established;

[0102] Step 8: Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in Step 6 and the standard working curve established in Step 7.

[0103] Example 3 A method for quantitative fluorescence detection of neutrophil gelatinase-associated apolipoprotein - method B

[0104] This example illustrates the method for fluorescent quantitative detection of neutrophil gelatinase-associated apolipoprotein (hereinafter referred to as method B) according to the present invention through another specific use step of the kit described in Example 1. The specific use steps are as follows:

[0105] Step 1: Dissolve the NGAL standard lyophilized powder with diluent to obtain a 1000 μg / L NGAL standard stock solution, and dilute the stock solution by two-fold gradient to obtain at least 4 concentration gradients of NGAL standard working solutions;

[0106] Step 2: dilute the biological sample to be tested with a diluent (preferably the dilution multiple of urine, cerebrospinal fluid and tears is ≥2 times, and the dilution multiple of other biological samples is ≥5 times) to obtain a sample test solution;

[0107] Step 3: Dissolve the NGAL fluorescent sensor freeze-dried powder in 10 mM Tris buffer (pH = 7.2-7.5, containing 100 mM NaCl) to prepare a 0.5 μM NGAL fluorescent sensor solution; heat at 95°C for 5-10 min, and then cool naturally to room temperature to obtain the NGAL fluorescent sensor working solution;

[0108] Step 4: Mix 25 μL of the NGAL standard working solution prepared in Step 1 and 25 μL of the sample test solution prepared in Step 2 with 25 μL of the NGAL fluorescent sensor working solution prepared in Step 3, respectively, and incubate at room temperature for ≥ 10 min to obtain solution B;

[0109] Step 5: Add 50 μL of the reporter molecule solution to solution B obtained in Step 4 and incubate at room temperature for 1 to 20 min;

[0110] Step 6: Use a fluorescence detector to detect the fluorescence signal of the reporter molecule, where the excitation wavelength is 440nm~450nm and the detection emission wavelength range is 480nm~490nm;

[0111] Step 7: According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution obtained in Step 6, a standard working curve of NGAL concentration and fluorescence signal intensity is established;

[0112] Step 8: Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in Step 6 and the standard working curve established in Step 7.

[0113] Example 4 Comparison of Fluorescence Quantitative Detection Method and ELISA Method for NGAL

[0114] In this example, the kit described in Example 1 and the two fluorescent quantitative detection methods for NGAL described in Example 2 and Example 3, Method A and Method B, and the ELISA quantitative method for NGAL disclosed by Linjun Cai et al. (Clin J Am Soc Nephrol. 2010 Dec; 5(12): 2229-2235) (ELISA1) were used to perform quantitative detection of NGAL on 40 clinical serum samples (15 serum samples from patients with renal injury and 15 serum samples from patients with bladder cancer, and 10 samples from a healthy control group) and the detection results were compared and analyzed.

[0115] When the above three methods are used for quantitative detection of NGAL, the NGAL standard working solution and the sample test solution are added to a 96-well fluorescence detection microplate in duplicate.

[0116] The specific steps of the above three methods for NGAL quantitative detection are as follows:

[0117] (1) The specific steps of method A described in Example 2 are as follows:

[0118] Step 1: Dissolve the NGAL standard lyophilized powder with diluent to obtain a 1000 μg / L NGAL standard stock solution, then dilute the NGAL standard stock solution by 2 times to obtain 10 concentration gradients of NGAL standard working solutions;

[0119] Step 2: Use diluent to dilute the serum sample 10 times in a gradient to obtain a sample test solution;

[0120] Step 3: Dissolve the NGAL fluorescent sensor freeze-dried powder in 10 mM Tris buffer (pH = 7.2-7.5, containing 100 mM NaCl) to prepare a 1 μM NGAL fluorescent sensor solution; heat at 95°C for 10 min, and then cool naturally to room temperature to obtain the NGAL fluorescent sensor working solution;

[0121] Step 4: Mix the reporter molecule solution and the NGAL fluorescent sensor working solution prepared in Step 3 in equal volumes and incubate at room temperature for 5 min to obtain solution A;

[0122] Step 5: Add 50 μL of NGAL standard working solution prepared in Step 1, 50 μL of sample test solution prepared in Step 2, and blank control (sample diluent) into the wells of a 96-well fluorescence detection microplate, and then add 50 μL of solution A prepared in Step 4 to each well, mix, and incubate at room temperature for 5 min;

[0123] Step 6: Use a multifunctional fluorescence microplate reader (ThermoFisher, VarioskanFlash) to detect fluorescence signals, where the excitation wavelength is 440nm~450nm and the detection emission wavelength range is 480nm~490nm;

[0124] Step 7: According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution obtained in Step 6, a standard working curve of NGAL concentration and fluorescence signal intensity is established;

[0125] Step 8: Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in Step 6 and the standard working curve established in Step 7.

[0126] (2) The specific steps of method B described in Example 3 are as follows:

[0127] Step 1: Dissolve the NGAL standard lyophilized powder with diluent to obtain a 1000 μg / L NGAL standard stock solution, and dilute the stock solution by 2 times to obtain 10 concentration gradients of NGAL standard working solutions;

[0128] Step 2: Use diluent to dilute the serum sample 10 times in a gradient to obtain a sample test solution;

[0129] Step 3: Dissolve the NGAL fluorescent sensor freeze-dried powder in 10 mM Tris buffer (pH = 7.2-7.5, containing 100 mM NaCl) to prepare a 0.5 μM NGAL fluorescent sensor solution; heat at 95°C for 10 min, and then cool naturally to room temperature to obtain the NGAL fluorescent sensor working solution;

[0130] Step 4: Add 25 μL of the NGAL standard working solution prepared in Step 1, 25 μL of the sample test solution prepared in Step 2, and 25 μL of the blank control (sample diluent) into the wells of a 96-well fluorescence detection microplate, and then add 25 μL of the NGAL fluorescent sensor working solution prepared in Step 3 to each well, mix, and incubate at room temperature for 20 min to obtain solution B;

[0131] Step 5: Add 50 μL of the reporter molecule solution to solution B obtained in Step 4 and incubate at room temperature for 5 min;

[0132] Step 6: Fluorescence signal detection was performed using a multifunctional fluorescence microplate reader (Thermo Fisher, Varioskan Flash), where the excitation wavelength was 445 nm and the detection emission wavelength range was 480 nm;

[0133] Step 7: According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution obtained in Step 6, a standard working curve of NGAL concentration and fluorescence signal intensity is established;

[0134] Step 8: Calculate the concentration of the sample test solution based on the fluorescence intensity of the sample test solution obtained in Step 6 and the standard working curve established in Step 7.

[0135] (3) The specific steps of the ELISA quantitative method (ELISA1) for NGAL disclosed by Linjun Cai et al. (Clin J Am Soc Nephrol. 2010 Dec; 5(12): 2229-2235) are as follows:

[0136] Step 1: Coat the ELISA plate (Nunc Maxsorp, Denmark) with rabbit anti-NGAL polyclonal antibody, where the NGAL polyclonal antibody was diluted to 5 μg / mL with 5 mM carbonate-bicarbonate buffer (pH 9.6), and coat each well with 100 μL at 4°C overnight;

[0137] Step 2: Wash the ELISA plate once with 10 mM phosphate buffer (pH = 7.4) containing 0.05% Tween-20;

[0138] Step 3: Add 200 μL of 5 mM carbonate-bicarbonate buffer (pH 9.6) containing 1% BSA to each well of the ELISA plate and block at 37°C for 30 min;

[0139] Step 4: Wash the ELISA plate twice with 10 mM phosphate buffer (pH = 7.4) containing 0.05% Tween-20;

[0140] Step 5: Add 100 μL of standard solution (1-64 μg / mL, 7 concentration gradients) or sample solution or blank control solution (phosphate buffer) to each well and incubate at room temperature for 1 h;

[0141] The sample solution was obtained by diluting the serum sample 20 times with 10 mM phosphate buffer (pH = 7.4);

[0142] Step 6: Wash the ELISA plate four times with 10 mM phosphate buffer (pH = 7.4) containing 0.05% Tween-20;

[0143] Step 7: Add 100 μL of NGAL monoclonal antibody (3F4E3) diluted in 10 mM phosphate buffer (pH = 7.4) (1:2000) to each well and incubate at room temperature for 1 h;

[0144] Step 8: Wash the ELISA plate four times with 10 mM phosphate buffer (pH = 7.4) containing 0.05% Tween-20;

[0145] Step 9: Add 100 μL of HRP-labeled goat anti-rabbit IgG (Sangon Biotechnology (Shanghai) Co., Ltd., D110058) diluted in 10 mM phosphate buffer (pH = 7.4) (1:3000) to each well and incubate at room temperature for 30 min;

[0146] Step 10: Wash the ELISA plate four times with 10 mM phosphate buffer (pH = 7.4) containing 0.05% Tween-20;

[0147] Step 11: Add 100 μL of 3,3',5,5'-tetramethylbenzidine solution to each well and react at room temperature for 20 min;

[0148] Step 12: Add 100 μL 1M H2S04 to each well to complete the reaction and measure the absorbance at 450 nm;

[0149] Step 13: Draw a standard curve based on the absorbance of the standard solution;

[0150] Step 14: Count the NGAL concentration of the sample based on the absorbance of the sample and the standard curve drawn in Step 13.

[0151] Table 2 NGAL standard gradient working solutions and their corresponding fluorescence signal intensities for the two fluorescence quantitative detection methods of NGAL in this embodiment

[0152]

[0153] Table 3 Concentrations of standard solutions and their corresponding absorbance values ​​for the ELISA quantitative method of NGAL described in this example

[0154]

[0155]

[0156] Table 4 Relative fluorescence intensity of serum samples measured by two fluorescence quantitative detection methods of NGAL in this embodiment, and Figure 2 and Figure 3 NGAL concentration in the sample solution calculated from the corresponding standard curve

[0157]

[0158]

[0159] Among them, the concentration A1 in Table 4 is the concentration of the sample after dilution 10 times calculated according to the fluorescence quantitative detection method A, the concentration A2 is the final concentration of the sample calculated according to the fluorescence quantitative detection method A; the concentration B1 is the final concentration of the sample calculated according to the fluorescence quantitative detection method B

[0160] The concentration of the sample after dilution 10 times is calculated, and the concentration B2 is the final concentration of the sample calculated according to the fluorescence quantitative detection method B; the concentration C1 is the concentration of the sample after dilution 20 times is calculated according to the ELISA method, and the concentration C2 is the final concentration of the sample calculated according to the ELISA method.

[0161] The results are as follows:

[0162] Table 2 shows the NGAL standard gradient working solutions and their corresponding fluorescence signal intensities for the two fluorescence quantitative detection methods of NGAL described in this example.

[0163] Table 3 shows the concentration of the standard solution and its corresponding absorbance value in the ELISA quantitative method of NGAL described in this example.

[0164] Figure 2 The standard curve of the NGAL fluorescence quantitative detection method (method A) in this embodiment is drawn according to the data in Table 2, wherein the abscissa is the NGAL concentration and the ordinate is the relative fluorescence intensity.

[0165] Figure 3 The standard curve of the NGAL fluorescence quantitative detection method (method B) in this embodiment is drawn according to the data in Table 2, wherein the abscissa is the NGAL concentration and the ordinate is the relative fluorescence intensity.

[0166] Figure 4 The standard curve of the ELISA quantitative method of NGAL in this embodiment is drawn according to the data in Table 3, wherein the abscissa is the NGAL concentration and the ordinate is the absorbance.

[0167] Table 4 shows the relative fluorescence intensity of serum samples measured by two fluorescence quantitative detection methods of NGAL in this embodiment, and Figure 2 and Figure 3 The NGAL concentration in the sample solution was calculated based on the corresponding standard curve; in addition, Table 4 also shows the absorbance of the serum sample measured by the ELISA quantitative method of NGAL described in this example, as well as Figure 4 The concentration of NGAL in the sample solution was calculated based on the standard curve.

[0168] Figure 5The figure is a graph showing the detection results of the same sample by the fluorescence quantitative detection method (method A) and the ELISA detection method of NGAL in this embodiment. The figure is drawn according to the data in Table 4, wherein the abscissa is the NGAL concentration in the sample measured by the fluorescence quantitative detection method (method A), and the ordinate is the NGAL concentration in the sample measured by the ELISA method.

[0169] Figure 6 The figure is a graph showing the detection results of the same sample by the fluorescence quantitative detection method (method B) of NGAL and the ELISA detection method of NGAL in this embodiment. The figure is drawn based on the data in Table 4, wherein the abscissa is the NGAL concentration in the sample measured by the fluorescence quantitative detection method B, and the ordinate is the NGAL concentration in the sample measured by the ELISA method.

[0170] Figure 7 The figure is a graph showing the detection results of the same sample by two fluorescent quantitative detection methods of NGAL in this embodiment. The figure is drawn according to the data in Table 4, wherein the horizontal axis is the NGAL concentration in the sample measured by the fluorescent quantitative detection method of NGAL (method A), and the vertical axis is the NGAL concentration in the sample measured by the fluorescent quantitative detection method of NGAL (method B).

[0171] In addition, the inventors of this case also referred to the aforementioned embodiments and conducted experiments with other raw materials, process operations, and process conditions described in this specification, and obtained relatively ideal results.

[0172] It should be understood that the technical solution of the present invention is not limited to the above-mentioned specific implementation cases. Any technical deformation made according to the technical solution of the present invention without departing from the scope of protection of the purpose of the present invention and the claims shall fall within the protection scope of the present invention.

Claims

1. A neutrophil gelatinase-associated lipocalin detection kit, It is characterized in that Including NGAL fluorescent sensor, reporter molecule, NGAL standard; Among them, the NGAL molecule can compete with the reporter molecule for binding to the NGAL fluorescent sensor; the NGAL fluorescent sensor includes a nucleotide chain having a G-quadruplex structure and a NGAL nucleic acid aptamer structure; the reporter molecule is a fluorescent dye molecule or a substance labeled with a fluorescent dye molecule that can specifically bind to the G-quadruplex structure and generate a fluorescent signal.

2. The neutrophil gelatinase-associated lipocalin detection kit according to claim 1, It is characterized in that The nucleotide chain sequence of the NGAL fluorescent sensor includes any one of SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6, SEQ ID No.7, SEQ ID No.8, SEQ ID No.9, and SEQ ID No.10, preferably SEQ ID No.

1.

3. The neutrophil gelatinase-associated lipocalin detection kit according to claim 1, It is characterized in that The fluorescent dye molecule includes any one of thioflavin T, N-methylmorpholine, 4-(2-aminoethoxy)-N2,N6-di[4-(2-aminoethoxy)-2-quinolyl]-2,6-pyridinedicarboxamide, triphenylmethanol-4,4',4"-tricarboxylic acid, BMVC, Cy5 or Cy7; the substance labeled by the fluorescent dye molecule includes any one of berberine, chelerythrine, G-quadruplex recognition peptide, G-quadruplex binding protein or G-quadruplex nucleic acid aptamer modified with fluorescent dye molecule.

4. The neutrophil gelatinase-associated lipocalin detection kit according to claim 1, It is characterized in that The kit also includes a diluent for diluting the NGAL standard and the sample to be detected, and the diluent includes Hepes buffer, phosphate buffer, and Tris buffer; the sample to be detected includes any biological sample of serum, plasma, urine, tears, saliva, cerebrospinal fluid, lung washing fluid, and tissue homogenate.

5. The neutrophil gelatinase-associated lipocalin detection kit according to claim 1, It is characterized in that The NGAL fluorescent sensor and the reporter molecule exist independently in the kit; or, the NGAL fluorescent sensor and the reporter molecule are pre-mixed and exist in the kit as a mixture.

6. Use of the neutrophil gelatinase-associated lipocalin detection kit according to any one of claims 1 to 5 in the preparation of a product for fluorescent detection of neutrophil gelatinase-associated lipocalin.

7. A fluorescence quantitative detection method for neutrophil gelatinase-associated apolipoprotein, It is characterized in that include: Using the diluent to perform gradient dilution on the NGAL standard to obtain a gradient working solution of the NGAL standard; Diluting the sample to be tested with a diluent to obtain a sample test solution; The NGAL fluorescent sensor is activated, and then mixed with the reporter molecule, the sample test solution, and the NGAL standard gradient working solution and incubated, and then fluorescence detection is performed to obtain the fluorescence signal intensity of the sample test solution and the NGAL standard gradient working solution; According to the NGAL concentration and the corresponding fluorescence signal intensity in the NGAL standard gradient working solution, a standard working curve of NGAL concentration and fluorescence signal intensity was established; According to the fluorescence signal intensity of the sample test solution and the standard working curve, the fluorescence quantitative detection of neutrophil gelatinase-associated lipocalin is achieved.

8. The fluorescence quantitative detection method according to claim 7, It is characterized in that The concentration of the gradient working solution of the NGAL standard is 1-1000 μg / L.

9. The fluorescence quantitative detection method according to claim 7, It is characterized in that The activation treatment includes any one of heat treatment method activation, cationic treatment method activation, and ultrasonic treatment method activation, preferably heat treatment method activation, wherein the conditions of the heat treatment method activation include: mixing Tris hydrochloric acid buffer and NGAL fluorescent sensor and heating at 95°C for 5 to 10 minutes.

10. The fluorescence quantitative detection method according to claim 7, It is characterized in that Specifically include: After the NGAL fluorescent sensor is mixed and incubated with the reporter molecule, it is then mixed with the gradient working solution of the NGAL standard or the sample test solution and incubated for 5 to 20 minutes before fluorescence signal detection; alternatively, the NGAL fluorescent sensor is mixed with the gradient working solution of the NGAL standard or the sample test solution and incubated for not less than 5 minutes, and then mixed with the reporter molecule and incubated for 1 to 20 minutes before fluorescence signal detection.